These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 16114155)

  • 1. The impact of luteal supplement on pregnancy outcome following stimulated IVF cycles.
    Tay PY; Lenton EA
    Med J Malaysia; 2005 Jun; 60(2):151-7. PubMed ID: 16114155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support in blastocyst stage embryo transfers.
    Wang LJ; Huang FJ; Kung FT; Lin PY; Chang SY; Lan KC
    Taiwan J Obstet Gynecol; 2009 Dec; 48(4):375-9. PubMed ID: 20045758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer.
    Mui Lam P; Chun Cheung M; Ping Cheung L; Ingrid Lok H; John Haines C
    Gynecol Endocrinol; 2008 Dec; 24(12):674-80. PubMed ID: 19172535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction.
    Kleinstein J;
    Fertil Steril; 2005 Jun; 83(6):1641-9. PubMed ID: 15950631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase support.
    Ludwig M; Finas A; Katalinic A; Strik D; Kowalcek I; Schwartz P; Felberbaum R; Küpker W; Schöpper B; Al-Hasani S; Diedrich K
    Acta Obstet Gynecol Scand; 2001 Jun; 80(6):574-82. PubMed ID: 11380297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support.
    Simunic V; Tomic V; Tomic J; Nizic D
    Fertil Steril; 2007 Jan; 87(1):83-7. PubMed ID: 17081536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Luteal phase support after vaginal progesterone: comparative study with micronized oral progesterone].
    Pouly JL; Bassil S; Frydman R; Hédon B; Nicollet B; Prada Y; Antoine JM; Zambrano R; Donnez J
    Contracept Fertil Sex; 1997; 25(7-8):596-601. PubMed ID: 9410372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal progesterone supplementation has no effect on ongoing pregnancy rate in hCG-induced natural frozen-thawed embryo transfer cycles.
    Kyrou D; Fatemi HM; Popovic-Todorovic B; Van den Abbeel E; Camus M; Devroey P
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):175-9. PubMed ID: 20219279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of progesterone secretion by oestradiol administered in the luteal phase of assisted conception cycles.
    Tay PY; Lenton EA
    Med J Malaysia; 2003 Jun; 58(2):187-95. PubMed ID: 14569738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
    Serna J; Cholquevilque JL; Cela V; Martínez-Salazar J; Requena A; Garcia-Velasco JA
    Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteal supplementation in in vitro fertilization: more questions than answers.
    Hubayter ZR; Muasher SJ
    Fertil Steril; 2008 Apr; 89(4):749-58. PubMed ID: 18406833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal use of micronized progesterone for luteal support.A randomized study comparing Utrogestan® and Crinone® 8.
    Michnova L; Dostal J; Kudela M; Hamal P; Langova K
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Mar; 161(1):86-91. PubMed ID: 28323291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greater implantation and pregnancy rates with vaginal progesterone in intracytoplasmic sperm injection but not in in vitro fertilization cycles: a retrospective study.
    Manno M; Marchesan E; Cicutto D; Zadro D; Favretti C; Tomei F
    Fertil Steril; 2005 May; 83(5):1391-6. PubMed ID: 15866574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A randomized prospective study comparing supplementation of the luteal phase and early pregnancy by natural progesterone administered by intramuscular or vaginal route].
    Smitz J; Devroey P; Faguer B; Bourgain C; Camus M; Van Steirteghem AC
    Rev Fr Gynecol Obstet; 1992 Oct; 87(10):507-16. PubMed ID: 1470824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol/progesterone substitution in the luteal phase improves pregnancy rates in stimulated cycles--but only in younger women.
    Gleicher N; Brown T; Dudkiewicz A; Karande V; Rao R; Balin M; Campbell D; Pratt D
    Early Pregnancy (Cherry Hill); 2000 Jan; 4(1):64-73. PubMed ID: 11719823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study.
    Yanushpolsky E; Hurwitz S; Greenberg L; Racowsky C; Hornstein M
    Fertil Steril; 2010 Dec; 94(7):2596-9. PubMed ID: 20347079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study.
    Chakravarty BN; Shirazee HH; Dam P; Goswami SK; Chatterjee R; Ghosh S
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):416-20. PubMed ID: 16213136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal (Crinone 8%) gel vs. intramuscular progesterone in oil for luteal phase support in in vitro fertilization: a large prospective trial.
    Silverberg KM; Vaughn TC; Hansard LJ; Burger NZ; Minter T
    Fertil Steril; 2012 Feb; 97(2):344-8. PubMed ID: 22188983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles.
    Mochtar MH; Van Wely M; Van der Veen F
    Hum Reprod; 2006 Apr; 21(4):905-8. PubMed ID: 16373409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study.
    Pirard C; Donnez J; Loumaye E
    Hum Reprod; 2006 Jul; 21(7):1894-900. PubMed ID: 16556673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.